摘要
目的确定丙泊酚增强全身麻醉诱导期甲苯磺酸瑞马唑仑(简称瑞马唑仑)镇静深度的半数有效剂量(ED_(50))和95%有效剂量(ED_(95))。方法选择在全身麻醉下行手术的患者,性别不限,年龄18~64岁,体质量50~80 kg,美国麻醉医师协会(ASA)分级Ⅰ级或Ⅱ级。采用序贯法进行试验。静脉注射舒芬太尼0.4μg/kg,米库氯铵0.2 mg/kg,瑞马唑仑0.3 mg/kg,设定丙泊酚初始剂量0.65 mg/kg,如果BIS值≤48,则下一例丙泊酚用量降低1个剂量梯度;若BIS值>48,在下一例增加1个剂量梯度。采用Probit法计算丙泊酚增强全身麻醉诱导期瑞马唑仑镇静深度的ED_(50)、ED_(95)及其95%置信区间(95%CI)。结果丙泊酚增强全身麻醉诱导期瑞马唑仑镇静深度的ED_(50)为0.45 mg/kg,95%CI为(0.42~0.49)mg/kg;ED_(95)为0.53 mg/kg,95%CI为(0.49~0.71)mg/kg。结论小剂量丙泊酚复合瑞马唑仑全麻诱导,在满足镇静深度的同时能较好维持血流动力学的稳定,丙泊酚增强全身麻醉诱导期瑞马唑仑镇静深度的ED_(50)为0.45 mg/kg,ED_(95)为0.53 mg/kg。
Objective To determine the median effective dose(ED_(50))and 95%effective dose(ED_(95))of propofol to enhance sedation depth of remimazolam tosilate(RMZ)during induction period of general anesthesia.Methods Patients who aged 18~64 years old with weighing 50~80 kg were enrolled.American Society of Anesthesiologists(ASA)hadⅠorⅡgrade.Sequential method was used to test.Anesthesia was induced with intravenous injection of sufentanil 0.4μg/kg,micuronium chloride 0.2 mg/kg,and RMZ 0.3 mg/kg.The initial dose of propofol was set as 0.65 mg/kg.If BIS≤48,dosage of propofol in the next case was reduced by one dose gradient.If BIS>48,a dose gradient was increased in the next case.Probit method analysis was used to calculate ED_(50),ED_(95) and 95%confidence interval(95%CI)of propofol enhanced sedation depth of BMZ during induction of general anesthesia.Results The ED_(50),ED_(95),and 95%CI of propofol enhanced sedation depth of BMZ during induction of general anesthesia were 0.45 mg/kg,(0.42~0.49)mg/kg and 0.53 mg/kg,(0.49~0.71)mg/kg,respectively.Conclusion Low dose propofol combined with RMZ could maintain hemodynamic stability while satisfying sedation depth.The ED_(50) and ED_(95) of propofol enhanced sedation depth of RMZ during induction of general anesthesia are 0.45 mg/kg and 0.53 mg/kg,respectively.
作者
张蓉
赵泽宇
王馨雪
程庆
李响
陈朝阳
Zhang Rong;Zhao Zeyu;Wang Xinxue(Department of Anesthesiology,Affiliated Sichuan Bayi Rehabilitation Center of Chengdu University of TCM,Chengdu,Sichuan 611135,China)
出处
《四川医学》
CAS
2021年第11期1105-1108,共4页
Sichuan Medical Journal
基金
四川省国际医学交流促进会基金项目(编号:L20200509004)。